Guru Ownership Trend
Guru Analysis for AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.16 M.
Top institutional holders include Renaissance Technologies and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $3.66 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 146.0%. Conversely, Renaissance Technologies reduced exposure by 28.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for AbCellera Biologics Inc. (ABCL)
Major holders include Renaissance Technologies ($8.17 M), Paul Tudor Jones ($6.14 M), Steven Cohen ($3.34 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 5.16 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3.66 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ABCL. The total reported sell value was $3.32 M.
Yes, 1 managers opened new positions in ABCL, and 1 increased their existing holdings. The total reported buy value was $6.98 M.